IDXX
IDEXX Laboratories, Inc.
Healthcare
$553.07
as of May 21, 2026
Sign in to add IDXX to your portfolio.
Sign inMarket cap
$43.67B
P/E (TTM)
40.5x
EPS (TTM)
$13.67
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $3.22B | $744.85M | $636.00M | 58.8% | 29.0% | $8.74 |
| 2022 | $3.37B | $679.09M | $394.15M | 59.5% | 26.7% | $8.12 |
| 2023 | $3.66B | $845.04M | $772.88M | 59.8% | 30.0% | $10.17 |
| 2024 | $3.90B | $887.87M | $798.08M | 61.0% | 29.0% | $10.77 |
| 2025 | $4.30B | $1.06B | $1.05B | 61.8% | 31.6% | $13.17 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $548.06 | $553.07 | 427.87K |
| May 20, 2026 | $546.14 | $553.58 | 617.64K |
| May 19, 2026 | $547.99 | $546.49 | 716.11K |
| May 18, 2026 | $532.16 | $545.79 | 633.93K |
| May 15, 2026 | $534.72 | $528.79 | 659.30K |
| May 14, 2026 | $528.68 | $532.86 | 786.10K |
| May 13, 2026 | $531.80 | $528.68 | 600.90K |
| May 12, 2026 | $534.24 | $533.92 | 674.17K |
| May 11, 2026 | $559.90 | $532.00 | 761.45K |
| May 08, 2026 | $572.20 | $560.11 | 476.64K |
| May 07, 2026 | $581.12 | $572.20 | 758.92K |
| May 06, 2026 | $561.85 | $579.23 | 665.24K |
| May 05, 2026 | $569.21 | $562.97 | 734.51K |
| May 04, 2026 | $564.51 | $563.12 | 711.88K |
| May 01, 2026 | $564.70 | $567.46 | 610.62K |
| Apr 30, 2026 | $554.33 | $560.80 | 717.10K |
| Apr 29, 2026 | $561.98 | $553.66 | 617.52K |
| Apr 28, 2026 | $575.16 | $568.30 | 539.19K |
| Apr 27, 2026 | $563.47 | $574.95 | 665.66K |
| Apr 24, 2026 | $556.92 | $565.93 | 598.22K |
| Apr 23, 2026 | $577.85 | $560.93 | 629.64K |
| Apr 22, 2026 | $570.86 | $578.35 | 364.70K |
| Apr 21, 2026 | $584.47 | $569.01 | 578.22K |
| Apr 20, 2026 | $582.67 | $583.06 | 638.20K |
Profitability & balance
- ROE (TTM)
- 70.9%
- Gross margin
- 62.1%
- Operating margin
- 31.6%
- Net margin
- 24.6%
- Debt / equity
- 0.69